Market Cap
$1.4B
AMN
AMN HEALTHCARE SERVICES INC
$36.63 ▲ +2.15%
Prev close $35.86Market cap$1.4B
ConsensusHold
12-mo target$36.14 (-1.3%)
▲ Neutral
Analyst conviction 5/10
High Impact Filing (7/10)31 New Institutional Positions19 Institutional Exits Services
Snapshot
The big-picture read on AMN right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Hold (46%)
Inst. Holders
50 funds
Inst. Value
$1.2B
Inst. Activity
31 buys / 19 sells
Insider Activity
$0.00 buy / $114.4K sell
Insider Net $
-$114.4K
SEC Reports
7
Price chart 30d +9.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 15, 2026 Insider
Laughlin Whitney M acquired via exercise 498 shares
Chief Legal Officer
Sep 15, 2026 Insider
Aug 12, 2026 SEC Laughlin Whitney M surrendered for taxes 122 shares
Chief Legal Officer @ $34.19 ($4.2K)
A bullish institutional cluster formed in AMN Healthcare during 2026-Q2, with 8 buyers adding $5.5M in net new positions
INST-CLUSTER — Impact 4/10
Aug 7, 2026 short_volume
Aug 6, 2026 SEC Short Volume: AMN — 73.4% short (0.4M / 0.6M)
Short: 419,046 | Exempt: 0 | TRF Vol: 571,150 | Short Ratio: 73.4% | Off-exchange volume (dark pool
AMN Healthcare reported Q2 2026 adjusted EPS of $0.77, massively beating the $0.19 consensus, on revenue of $673M vs. $6
PRESS-RELEASE — Impact 6/10
Jun 30, 2026 Inst.
MORGAN STANLEY — ADD
2,282,597 shares ($73.9M)
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP — ADD
1,283,381 shares ($41.5M)
Jun 15, 2026 Insider
FOLETTA MARK G sold 1,681 shares
Director @ $31.07 ($52.2K)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
46% rate it Buy or better · 13 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 11, 2026 | BMO Capital | MAINTAIN | Outperform | 53% |
| Aug 14, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| Aug 7, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 22, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
| Jun 23, 2026 | Citizens | REITERATE | Market Outperform | 38% |
| May 13, 2026 | UBS | MAINTAIN | Neutral | 55% |
| May 11, 2026 | BMO Capital | MAINTAIN | Outperform | 53% |
| May 11, 2026 | Baird | MAINTAIN | Neutral | 54% |
| May 8, 2026 | Truist Securities | MAINTAIN | Buy | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Aug 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Jul 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Jun 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| May 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Apr 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Mar 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% | |
| Feb 1, 2026 | 1 | 5 | 6 | 1 | 0 | 46% |
Price targets
Where 7 covering analysts think AMN trades over the next 12 months.
$36.14 -1.3% upside Hold
Current$36.63 Low$28.00 Median$36.00 High$40.00 7 analysts
$28.00$40.00
Analyst rating Hold· 2.6/5 as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 2 bullish, 1 bearish, 2 mixed, 2 neutral · avg impact 4.7/10.
BULLISHINST-CLUSTER4/10
A bullish institutional cluster formed in AMN Healthcare during 2026-Q2, with 8 buyers adding $5.5M
Aug 12, 2026
MIXEDPRESS-RELEASE6/10
AMN Healthcare reported Q2 2026 adjusted EPS of $0.77, massively beating the $0.19 consensus, on rev
Aug 6, 2026
MIXEDINST-CLUSTER5/10
An institutional cluster in AMN shows mixed conviction: 4 quant/mega-passive buyers accumulated $39.
Jun 11, 2026
NEUTRAL8-K2/10
AMN Healthcare shareholders approved Amendment No. 1 to the 2025 Equity Plan at the Annual Meeting o
May 4, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 7, 2026
short_volume
Short Volume: AMN — 73.4% short (0.4M / 0.6M)
Short: 419,046 | Exempt: 0 | TRF Vol: 571,150 | Short Ratio: 73.4% | Off-exchange volume (dark pool + OTC)
Aug 6, 2026
earnings
AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS
Quarterly revenue of $673 million and adjusted EBITDA of $73 million; GAAP income of $0.53/share and adjusted EPS of $0.77 DALLAS, Aug. 6, 2026 /PRNew
Aug 6, 2026
earnings_calendar
AMN Q2 2026 Earnings After Market Close — 2026-08-06
Jul 13, 2026
short_volume
Short Volume: AMN — 74.3% short (0.4M / 0.6M)
Short: 424,212 | Exempt: 0 | TRF Vol: 570,616 | Short Ratio: 74.3% | Off-exchange volume (dark pool + OTC)
Jul 7, 2026
earnings
AMN Healthcare to Hold Second Quarter 2026 Earnings Conference Call on Thursday, August 6, 2026
DALLAS, July 7, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2026 fin
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.23 | $0.18–$0.25 | -41.4% | +0.0% | 8↑ 1↓ | $0.6B | 9 |
| Next Q | $0.21 | $0.09–$0.32 | -5.6% | +0.0% | 3↑ 5↓ | $0.7B | 9 |
| Current FY | $3.29 | $3.17–$3.44 | 141.7% | +0.0% | 9↑ 0↓ | $3.4B | 9 |
| Next FY | $0.94 | $0.74–$1.36 | -71.5% | +0.0% | 3↑ 6↓ | $2.7B | 9 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.229 | — |
| 7d ago | $0.229 | — |
| 30d ago | $0.229 | — |
| 60d ago | $0.170 | +0.058 |
| 90d ago | $0.170 | +0.058 |
Institutional ownership
Which big funds own AMN (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.2B total value (35,701,450 shares) as of 2026-Q2. Top holders: BlackRock,, MORGAN, VANGUARD. Net buying activity: 31 institutions added/increased vs 19 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 6,643,401 | $215.0M | 18.6% | — |
| MORGAN STANLEY | 2,282,597 | $73.9M | 6.4% | ADD +70.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,719,045 | $55.6M | 4.8% | — |
| STATE STREET CORP | 1,694,316 | $54.8M | 4.7% | — |
| Boston Partners | 1,674,561 | $54.2M | 4.7% | — |
| Allianz Asset Management GmbH | 1,402,948 | $45.4M | 3.9% | — |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,391,859 | $45.1M | 3.9% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,288,073 | $41.7M | 3.6% | — |
| DIMENSIONAL FUND ADVISORS LP | 1,283,381 | $41.5M | 3.6% | ADD +73.1% |
| TWO SIGMA INVESTMENTS, LP | 1,158,258 | $37.5M | 3.2% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 1,340,675 | 2,282,597 | +70.3% | $73.9M |
| DIMENSIONAL FUND ADVISORS LP | ADD | 741,209 | 1,283,381 | +73.1% | $41.5M |
| AMERIPRISE FINANCIAL INC | DOUBLED | 81,844 | 1,051,103 | +1184.3% | $34.0M |
| UBS Group AG | TRIM | 867,976 | 646,553 | -25.5% | $20.9M |
| D. E. Shaw & Co., Inc. | TRIM | 891,142 | 550,638 | -38.2% | $17.8M |
| Qube Research & Technologies Ltd | NEW | — | 342,767 | — | $11.1M |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | ADD | 176,597 | 223,265 | +26.4% | $7.2M |
| Connor, Clark & Lunn Investment Management Ltd. | DOUBLED | 18,579 | 186,796 | +905.4% | $6.0M |
| Empowered Funds, LLC | TRIM | 268,007 | 168,798 | -37.0% | $5.5M |
| ROYAL BANK OF CANADA | DOUBLED | 55,755 | 159,190 | +185.5% | $5.2M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
12 insiders, 40 transactions. Net -$114.4K — $0.00 bought, $114.4K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Laughlin Whitney M | Chief Legal Officer | EXERCISE | 498 | — | — |
| Sep 15, 2026 | Laughlin Whitney M | Chief Legal Officer | TAX W/H | 122 | $34.19 | $4.2K |
| Jun 15, 2026 | FOLETTA MARK G | Director | SELL | 1,681 | $31.07 | $52.2K |
| Jun 15, 2026 | FOLETTA MARK G | Director | SELL | 2,000 | $31.07 | $62.1K |
| May 1, 2026 | Jones Daphne E | Director | AWARD | 8,304 | — | — |
| May 1, 2026 | Jones Daphne E | Director | EXERCISE | 8,325 | — | — |
| May 1, 2026 | Huber Celia P | Director | AWARD | 8,304 | — | — |
| May 1, 2026 | Caballero Jorge A. | Director | EXERCISE | 8,325 | — | — |
| May 1, 2026 | Caballero Jorge A. | Director | AWARD | 8,304 | — | — |
| May 1, 2026 | FOLETTA MARK G | Director | EXERCISE | 8,325 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for AMN.
Shares short
3,488,132
Settlement Sep 15, 2026
Change vs prior
+2.0%
Semi-monthly cycle
Days to cover
5.9
At avg daily volume
Of shares outstanding
≈9.0%
Estimate — not % of float
All AMN filing & press-release reports (7)
- INST-CLUSTER reportAug 12, 2026
- PRESS-RELEASE reportAug 6, 2026
- INST-CLUSTER reportJun 11, 2026
- 8-K reportMay 4, 2026
- PRESS-RELEASE reportApr 9, 2026
- DEFA14A reportMar 18, 2026
- INST-CLUSTER reportFeb 28, 2026